HLA-DR risk variants in rheumatoid arthritis: what we know and still do not know. [PDF]
Yap CF, Viatte S.
europepmc +1 more source
HLA Class I Loss and Resistance to Immunotherapy in Pulmonary Metastasis of Hypopharyngeal Cancer. [PDF]
Murakami A +6 more
europepmc +1 more source
Targeting non-canonical antigens unlocks functional T-cell responses in renal cell carcinoma. [PDF]
Wang J +13 more
europepmc +1 more source
Human Leukocyte Antigen Determinants in Myocarditis and Dilated Cardiomyopathy. [PDF]
Goli N, Wilcox J, Barnard J, Tang WHW.
europepmc +1 more source
How Epstein-Barr Virus Drives Multiple Sclerosis: New Mechanisms and Therapeutic Lessons. [PDF]
Liu D, Fan W, Jiao P.
europepmc +1 more source
Multiparameter antigen-specific immunoprofiling in subjects with negative IGRA and TST results with potential <i>M. tuberculosis</i> exposures. [PDF]
Pathakumari B +13 more
europepmc +1 more source
Nomenclature for Factors of the HLA System, 2026. [PDF]
Marsh SGE +14 more
europepmc +1 more source
HLA-DR antigens in tuberculoid and lepromatous leprosy
T H, Rea, P I, Terasaki
openaire +2 more sources
Organ allocation and transplant equity in Brazil: the hidden burden of HLA homozygosity and hypersensitization. [PDF]
Santos Júnior ACSD +4 more
europepmc +1 more source

